370 related articles for article (PubMed ID: 21593402)
1. Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells.
Sagoo P; Ali N; Garg G; Nestle FO; Lechler RI; Lombardi G
Sci Transl Med; 2011 May; 3(83):83ra42. PubMed ID: 21593402
[TBL] [Abstract][Full Text] [Related]
2. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.
Putnam AL; Safinia N; Medvec A; Laszkowska M; Wray M; Mintz MA; Trotta E; Szot GL; Liu W; Lares A; Lee K; Laing A; Lechler RI; Riley JL; Bluestone JA; Lombardi G; Tang Q
Am J Transplant; 2013 Nov; 13(11):3010-20. PubMed ID: 24102808
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo.
Sawitzki B; Kingsley CI; Oliveira V; Karim M; Herber M; Wood KJ
J Exp Med; 2005 Jun; 201(12):1925-35. PubMed ID: 15967822
[TBL] [Abstract][Full Text] [Related]
4. In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.
Golshayan D; Jiang S; Tsang J; Garin MI; Mottet C; Lechler RI
Blood; 2007 Jan; 109(2):827-35. PubMed ID: 17003369
[TBL] [Abstract][Full Text] [Related]
5. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
[TBL] [Abstract][Full Text] [Related]
6. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects Alloantigen Recognition and Peripheral Treg Phenotype of Lung Transplant Recipients.
Siemeni T; Knöfel AK; Madrahimov N; Sommer W; Avsar M; Salman J; Ius F; Frank N; Büchler G; Jonigk D; Jansson K; Maus U; Tudorache I; Falk CS; Haverich A; Warnecke G
Am J Transplant; 2016 Nov; 16(11):3150-3162. PubMed ID: 27273729
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
9. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
[TBL] [Abstract][Full Text] [Related]
10. Novel GMP-compatible protocol employing an allogeneic B cell bank for clonal expansion of allospecific natural regulatory T cells.
Landwehr-Kenzel S; Issa F; Luu SH; Schmück M; Lei H; Zobel A; Thiel A; Babel N; Wood K; Volk HD; Reinke P
Am J Transplant; 2014 Mar; 14(3):594-606. PubMed ID: 24467477
[TBL] [Abstract][Full Text] [Related]
11. T-reg mediated suppression of the allograft response in the draining lymph node.
Lee MK; Moore DJ; Chiaccio M; Lian MM; Deng S; Mohiuddin M; Huang X; Koeberlein B; Zakheim A; Porrett PM; Barker CF; Caton AJ; Markmann JF
Transplantation; 2006 Apr; 81(7):1063-6. PubMed ID: 16612285
[TBL] [Abstract][Full Text] [Related]
12. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.
Zheng J; Liu Y; Liu Y; Liu M; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
Sci Transl Med; 2013 Jan; 5(168):168ra9. PubMed ID: 23325802
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
[TBL] [Abstract][Full Text] [Related]
14. Alloantigen-specific prolongation of allograft survival in recipient mice treated by alloantigen immunization following ultraviolet-B irradiation.
Hori T; Kuribayashi K; Uemoto S; Saito K; Wang L; Torii M; Shibutani S; Taniguchi K; Yagi S; Iida T; Yamamoto C; Kato T
Transpl Immunol; 2008 Apr; 19(1):45-54. PubMed ID: 18346637
[TBL] [Abstract][Full Text] [Related]
15. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor.
MacDonald KG; Hoeppli RE; Huang Q; Gillies J; Luciani DS; Orban PC; Broady R; Levings MK
J Clin Invest; 2016 Apr; 126(4):1413-24. PubMed ID: 26999600
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ T Regulatory Cells in Transplantation Tolerance: 25 Years On.
Hall BM
Transplantation; 2016 Dec; 100(12):2533-2547. PubMed ID: 27861285
[TBL] [Abstract][Full Text] [Related]
17. Cytokines affecting CD4
Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ
Transpl Immunol; 2017 Aug; 43-44():33-41. PubMed ID: 28652007
[TBL] [Abstract][Full Text] [Related]
18. Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use.
Alzhrani A; Bottomley M; Wood K; Hester J; Issa F
Cell Immunol; 2020 Nov; 357():104214. PubMed ID: 32977154
[TBL] [Abstract][Full Text] [Related]
19. Cytokines affecting CD4
Nomura M; Hodgkinson SJ; Tran GT; Verma ND; Robinson C; Plain KM; Boyd R; Hall BM
Transpl Immunol; 2017 Jun; 42():24-33. PubMed ID: 28487237
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation.
Davies JK; Barbon CM; Voskertchian A; Nadler LM; Guinan EC
Cell Transplant; 2012; 21(9):2047-61. PubMed ID: 22507909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
